Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder

Detalhes bibliográficos
Autor(a) principal: Diniz, Juliana Belo
Data de Publicação: 2011
Outros Autores: Malavazzi, Dante Marino, Fossaluza, Victor, Belotto-Silva, Cristina, Borcato, Sonia, Pimentel, Izabel, Miguel, Euripedes Constantino, Shavitt, Roseli Gedanke
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/19225
Resumo: INTRODUCTION: In obsessive-compulsive disorder, early treatment discontinuation can hamper the effectiveness of first-line treatments. OBJECTIVE: This study aimed to investigate the clinical correlates of early treatment discontinuation among obsessive-compulsive disorder patients. METHODS: A group of patients who stopped taking selective serotonin reuptake inhibitors (SSRIs) or stopped participating in cognitive behavioral therapy before completion of the first twelve weeks (total n = 41; n = 16 for cognitive behavioral therapy and n = 25 for SSRIs) were compared with a paired sample of compliant patients (n = 41). Demographic and clinical characteristics were obtained at baseline using structured clinical interviews. Chisquare and Mann-Whitney tests were used when indicated. Variables presenting a p value
id USP-19_ca558cdd75a3f2830a07a0d5071154d9
oai_identifier_str oai:revistas.usp.br:article/19225
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder Obsessive-compulsive disorderAnxiety disordersSomatoform disordersFirst-line treatmentsPatient compliance INTRODUCTION: In obsessive-compulsive disorder, early treatment discontinuation can hamper the effectiveness of first-line treatments. OBJECTIVE: This study aimed to investigate the clinical correlates of early treatment discontinuation among obsessive-compulsive disorder patients. METHODS: A group of patients who stopped taking selective serotonin reuptake inhibitors (SSRIs) or stopped participating in cognitive behavioral therapy before completion of the first twelve weeks (total n = 41; n = 16 for cognitive behavioral therapy and n = 25 for SSRIs) were compared with a paired sample of compliant patients (n = 41). Demographic and clinical characteristics were obtained at baseline using structured clinical interviews. Chisquare and Mann-Whitney tests were used when indicated. Variables presenting a p value Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1922510.1590/S1807-59322011000300004Clinics; v. 66 n. 3 (2011); 387-393 Clinics; Vol. 66 Núm. 3 (2011); 387-393 Clinics; Vol. 66 No. 3 (2011); 387-393 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19225/21288Diniz, Juliana BeloMalavazzi, Dante MarinoFossaluza, VictorBelotto-Silva, CristinaBorcato, SoniaPimentel, IzabelMiguel, Euripedes ConstantinoShavitt, Roseli Gedankeinfo:eu-repo/semantics/openAccess2012-05-23T16:28:21Zoai:revistas.usp.br:article/19225Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-23T16:28:21Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
title Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
spellingShingle Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
Diniz, Juliana Belo
Obsessive-compulsive disorder
Anxiety disorders
Somatoform disorders
First-line treatments
Patient compliance
title_short Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
title_full Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
title_fullStr Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
title_full_unstemmed Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
title_sort Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
author Diniz, Juliana Belo
author_facet Diniz, Juliana Belo
Malavazzi, Dante Marino
Fossaluza, Victor
Belotto-Silva, Cristina
Borcato, Sonia
Pimentel, Izabel
Miguel, Euripedes Constantino
Shavitt, Roseli Gedanke
author_role author
author2 Malavazzi, Dante Marino
Fossaluza, Victor
Belotto-Silva, Cristina
Borcato, Sonia
Pimentel, Izabel
Miguel, Euripedes Constantino
Shavitt, Roseli Gedanke
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Diniz, Juliana Belo
Malavazzi, Dante Marino
Fossaluza, Victor
Belotto-Silva, Cristina
Borcato, Sonia
Pimentel, Izabel
Miguel, Euripedes Constantino
Shavitt, Roseli Gedanke
dc.subject.por.fl_str_mv Obsessive-compulsive disorder
Anxiety disorders
Somatoform disorders
First-line treatments
Patient compliance
topic Obsessive-compulsive disorder
Anxiety disorders
Somatoform disorders
First-line treatments
Patient compliance
description INTRODUCTION: In obsessive-compulsive disorder, early treatment discontinuation can hamper the effectiveness of first-line treatments. OBJECTIVE: This study aimed to investigate the clinical correlates of early treatment discontinuation among obsessive-compulsive disorder patients. METHODS: A group of patients who stopped taking selective serotonin reuptake inhibitors (SSRIs) or stopped participating in cognitive behavioral therapy before completion of the first twelve weeks (total n = 41; n = 16 for cognitive behavioral therapy and n = 25 for SSRIs) were compared with a paired sample of compliant patients (n = 41). Demographic and clinical characteristics were obtained at baseline using structured clinical interviews. Chisquare and Mann-Whitney tests were used when indicated. Variables presenting a p value
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19225
10.1590/S1807-59322011000300004
url https://www.revistas.usp.br/clinics/article/view/19225
identifier_str_mv 10.1590/S1807-59322011000300004
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19225/21288
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; v. 66 n. 3 (2011); 387-393
Clinics; Vol. 66 Núm. 3 (2011); 387-393
Clinics; Vol. 66 No. 3 (2011); 387-393
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1787713172153565184

Registros relacionados